New technique developed by UAlberta researchers vastly improves precision of gene-editing technology.
Imagine a future where a guided biomachine put into your body seeks out defective gene sequences in each cell and edits in the correct information with precision accuracy.
It’s called gene editing, and University of Alberta researchers have just published a game-changing study that promises to bring the technology much closer to therapeutic reality.
“We’ve discovered a way to greatly improve the accuracy of gene-editing technology by replacing the natural guide molecule it uses with a synthetic one called a bridged nucleic acid, or BNA,” said Basil Hubbard, Canada Research Chair in Molecular Therapeutics and an assistant professor in the U of A’s Department of Pharmacology, who led the study.
He and his team have filed a patent on their discovery and are hoping to partner with the pharmaceutical industry to incorporate it into a therapeutic.
Interest in gene-editing technology has been rapidly rising since the discovery of CRISPR/Cas9. This system is naturally present in bacteria, which use it for protection against their natural predators, called bacteriophages.
“It allows bacteria to store information about previous infections and then use it to seek out and destroy the DNA of new invaders by cutting it,” explained Hubbard.
“What researchers have realized is that this system can be programmed to cut a specific DNA sequence in a human cell also, allowing us to edit our genes. One of the main issues, however, is that the system is not perfectly specific—sometimes it cuts a similar but incorrect gene.”
Using its natural RNA guide molecule, the Cas9 system is quite accurate, only making a mistake about one per cent of the time, he noted.
“However, given that there are trillions of cells in the human body, even one percentage off is quite significant, especially because gene editing is permanent. One wrong cut and a patient could end up with a serious condition like cancer.”
The new BNA guide molecule that Hubbard and his team—which includes PhD student Christopher Cromwell, who is first author on the study—developed was shown to be much more stable and stringent in its quest for finding the right DNA to cut.
“Our research shows that the use of bridged nucleic acids to guide Cas9 can improve its specificity by over 10,000 times in certain instances—a dramatic improvement,” said Hubbard.
Though gene-editing technology still has several hurdles to overcome, including the challenge of how to deliver it effectively into the human body, it may someday be used to treat a wide variety of genetic diseases, from muscular dystrophy to hemophilia and various cancers.
The Latest on: Gene editing
via Google News
The Latest on: Gene editing
- Gene therapy cuts fat and builds muscle in sedentary mice on unhealthy dietson May 11, 2020 at 5:55 am
A single injection of the gene that makes the protein follistatin caused a significant buildup of muscle mass in mice while also preventing obesity, reported Washington University researchers. The ...
- Dyno Debuts With Plan, Partnerships For Better Gene Therapy Vectorson May 11, 2020 at 4:04 am
He was exposed to gene therapy through Church’s work with the gene editing technology CRISPR-Cas9, one of the tools being deployed to address genetic diseases. “It just seemed like the perfect ...
- Study reveals key gene related to primate arterial agingon May 10, 2020 at 11:35 pm
Chinese researchers have identified a gene that is related to arterial aging in primates. Age-related changes in artery properties are high-risk factors for some cardiovascular diseases. But ...
- Does gene editing hold key to better healthcare?on May 9, 2020 at 5:53 am
So, what is gene editing? This medical innovation, also called genome editing or gene engineering, involves the use of biotechnological methods to alter the genetic makeup of animals or plants with ...
- First-ever coronavirus test that uses gene-editing tool CRISPR that glows when the virus is detected and gives results in just one hour is approved by FDAon May 8, 2020 at 8:11 am
The new coronavirus test uses a CRISPR molecule that can find viral RNA instead of human DNA, in nose and throat samples, and glows when it's been found due to a fluorescent marker.
- Cambridge biotech’s virus test using CRISPR gene editing OK’d for crisison May 7, 2020 at 5:27 pm
Initially, Sherlock plans to initially sell enough tests for hospital laboratories to check at least 10,000 patients a week for the coronavirus. The company could ultimately do a million tests a week ...
- FDA OK’s first-ever use of gene-editing tool CRISPR to tackle Covid-19on May 7, 2020 at 7:00 am
This is an absolutely historic moment for biotech and healthcare, in that CRISPR has come of age," Sherlock Biosciences CEO told the Business Journal. A new diagnostic test is reportedly 100% accurate ...
- Gene Editing Market Insights, Segments Insight with Statistics and Growth Prediction 2020 to 2027on May 7, 2020 at 5:32 am
According to the Acumen Research, The global Gene Editing Market is expected to reach a value of more than US$ 9.2 Billion by 2027 and expanding at a CAGR of 15.3% during the forecast period. The ...
- Harvard’s Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editingon May 5, 2020 at 10:39 pm
The development of CRISPR technology has long been a focus in his research group at the Wyss Institute and HMS with multiple key breakthroughs in the genome editing field that also led to the ...
via Bing News